Legend Biotech Corp (LEGN) — Cash Flow Reinvestment Rate
Legend Biotech Corp (LEGN) has a Cash Flow Reinvestment Rate of 0.87x as of September 2025, reinvesting $25.01 Million (capex $5.00 Million plus investments $-20.00 Million) from operating cash flow of $28.80 Million. Explore Legend Biotech Corp (LEGN) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Legend Biotech Corp Cash Flow Reinvestment Rate (2018–2018)
Historical reinvestment intensity for Legend Biotech Corp across 1 annual periods. Also explore Legend Biotech Corp (LEGN) total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Legend Biotech Corp (2018–2018)
Year-by-year capital reinvestment analysis for Legend Biotech Corp. For live market cap and broader valuation context, see LEGN company net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2018 | 0.40x | $123.28 Million | $307.68 Million | $21.02 Million | — |